Alkyl Amines Chemicals Limited carries a market capitalization of 93.94B, placing it among publicly traded companies globally. Its enterprise value stands at 121.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 93.94B |
| Enterprise Value | 121.08B |
Alkyl Amines Chemicals Limited trades at a trailing price-to-earnings ratio of 64.86.
| PE Ratio | 64.86 |
| PS Ratio | 7.67 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Alkyl Amines Chemicals Limited trades at an EV/EBITDA multiple of 55.76 and an EV/FCF ratio of 14,553.49. The EV/Sales ratio of 7.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 55.76 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.67 |
| EV / EBITDA | 55.76 |
| EV / EBIT | 55.76 |
| EV / FCF | 14,553.49 |
Alkyl Amines Chemicals Limited maintains a current ratio of 4.70, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.56, indicating moderate leverage, while an interest coverage ratio of 195.62 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.70 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | N/A |
| Interest Coverage | 195.62 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 304.98 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Alkyl Amines Chemicals Limited has paid 623.90M in income taxes, reflecting an effective tax rate of 25.05.
| Income Tax | 623.90M |
| Effective Tax Rate | 25.05 |
Alkyl Amines Chemicals Limited's stock has declined approximately -6.16123% over the past 52 weeks. The 50-day moving average sits at 1,531.90, while the 200-day moving average is 1,659.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.16123% |
| 50-Day Moving Average | 1,531.90 |
| 200-Day Moving Average | 1,659.09 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Alkyl Amines Chemicals Limited generated 15.78B in revenue and converted that into 1.87B in net income, yielding earnings per share of 36.46. EBITDA reached 2.17B, while operating income came in at 2.17B.
| Revenue | 15.78B |
| Gross Profit | 7.31B |
| Operating Income | 2.17B |
| Pretax Income | 2.49B |
| Net Income | 1.87B |
| EBITDA | 2.17B |
| EBIT | 2.17B |
| Earnings Per Share (EPS) | 36.46 |
Alkyl Amines Chemicals Limited operates with a gross margin of 46.32, reflecting its pricing power and cost economics. The operating margin of 13.76 and net profit margin of 11.83 provide insight into operational efficiency.
| Gross Margin | 46.32 |
| Operating Margin | 13.76 |
| Pretax Margin | 15.79 |
| Profit Margin | 11.83 |
| EBITDA Margin | 13.76 |
Alkyl Amines Chemicals Limited's most recent stock split took place on May 11, 2021 with a 2:5 split ratio.
| Last Split Date | 5/11/2021 |
| Split Ratio | 2:5 |
Alkyl Amines Chemicals Limited posts an Altman Z-Score of 34.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 34.83 |